Black Diamond Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at Black Diamond Therapeutics, Bespoke Extracts, and Vivos have recently purchased shares in their respective companies. Black Diamond Therapeutics' 10% owner BB Biotech AG acquired 400,000 shares at an average price of $2.34. Bespoke Extracts' CEO Michael Feinsod bought 3,000 shares at an average price of $0.20. Vivos' CEO and President Micheal Korenko purchased 100,000 shares at an average price of $0.05.
October 20, 2023 | 12:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BB Biotech AG, a 10% owner of Black Diamond Therapeutics, acquired 400,000 shares at an average price of $2.34.
Insider buying is often seen as a positive sign as it indicates that insiders believe in the company's prospects. This could potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Bespoke Extracts' CEO Michael Feinsod acquired 3,000 shares at an average price of $0.20.
The CEO's purchase of shares indicates a belief in the company's future performance. This could potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Vivos' CEO and President Micheal Korenko purchased 100,000 shares at an average price of $0.05.
The CEO's purchase of shares indicates a belief in the company's future performance. This could potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100